85 related articles for article (PubMed ID: 2487422)
1. [Antitumor concomitant immunity: a possible metastasis control mechanism].
Ruggiero RA; Bustuoadad OD; Bonfil RD; Sordelli DO; Fontan P; Meiss RP; Pasqualini CD
Medicina (B Aires); 1989; 49(3):277-81. PubMed ID: 2487422
[TBL] [Abstract][Full Text] [Related]
2. In vivo destruction of tumor tissue by cryoablation can induce inhibition of secondary tumor growth: an experimental study.
Joosten JJ; Muijen GN; Wobbes T; Ruers TJ
Cryobiology; 2001 Feb; 42(1):49-58. PubMed ID: 11336489
[TBL] [Abstract][Full Text] [Related]
3. A syngeneic metastatic tumor model in mice: the natural immune response of the host and its manipulation.
Treves AJ; Cohen IR; Feldman M
Isr J Med Sci; 1976; 12(4-5):369-84. PubMed ID: 1084880
[TBL] [Abstract][Full Text] [Related]
4. Immunogenetic studies on the resistance of mice to highly metastatic DBA/2 tumor cell variants. I. Effect of incompatibilities at H-2 or non-H-2 genes in normal and nude (nu/nu) mice.
Schirrmacher V
Invasion Metastasis; 1981; 1(1):4-21. PubMed ID: 7188381
[TBL] [Abstract][Full Text] [Related]
5. Is immunosuppression at the tumor site mechanism of evasion of a systemic response?
Karakousis CP; Sharma S; Brooks SP
J Med; 2003; 34(1-6):3-14. PubMed ID: 17682306
[TBL] [Abstract][Full Text] [Related]
6. Effects of concomitant and sinecomitant immunity on postsurgical metastasis in mice.
Nomi S; Naito K; Kahan BD; Pellis NR
Cancer Res; 1986 Dec; 46(12 Pt 1):6111-5. PubMed ID: 3779631
[TBL] [Abstract][Full Text] [Related]
7. Histologic aspects of concomitant resistance induced by nonimmunogenic murine tumors.
Meiss RP; Bonfil RD; Ruggiero RA; Pasqualini CD
J Natl Cancer Inst; 1986 Jun; 76(6):1163-75. PubMed ID: 3458952
[TBL] [Abstract][Full Text] [Related]
8. Immune rejection of metastases arising from intraocular tumors in mice.
Niederkorn JY; Knisely TL; Mayhew E
Invest Ophthalmol Vis Sci; 1986 Sep; 27(9):1355-61. PubMed ID: 3091527
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-12 gene therapy of a weakly immunogenic mouse mammary carcinoma results in reduction of spontaneous lung metastases via a T-cell-independent mechanism.
Rakhmilevich AL; Janssen K; Hao Z; Sondel PM; Yang NS
Cancer Gene Ther; 2000 Jun; 7(6):826-38. PubMed ID: 10880012
[TBL] [Abstract][Full Text] [Related]
10. [Concomitant antitumor resistance].
Ruggiero RA; Di Gianni PD; Franco M; Bustuoabad OD
Medicina (B Aires); 1996; 56 Suppl 1():57-64. PubMed ID: 9224975
[TBL] [Abstract][Full Text] [Related]
11. Isolation and reactivity of host effectors associated with the manifestation of concomitant tumor immunity.
Akporiaye ET; Kudalore M; Stevenson AP; Kraemer PM; Stewart CC
Cancer Res; 1988 Mar; 48(5):1153-8. PubMed ID: 3257713
[TBL] [Abstract][Full Text] [Related]
12. Endogenous IL-21 restricts CD8+ T cell expansion and is not required for tumor immunity.
Søndergaard H; Coquet JM; Uldrich AP; McLaughlin N; Godfrey DI; Sivakumar PV; Skak K; Smyth MJ
J Immunol; 2009 Dec; 183(11):7326-36. PubMed ID: 19915059
[TBL] [Abstract][Full Text] [Related]
13. Quantitative studies on the transplantability of murine and human tumors into the brain and subcutaneous tissues of NCr/Sed nude mice.
Zietman AL; Suit HD; Ramsay JR; Silobrcic V; Sedlacek RS
Cancer Res; 1988 Nov; 48(22):6510-6. PubMed ID: 3052803
[TBL] [Abstract][Full Text] [Related]
14. T lymphocytes infiltrating sites of tumor rejection and progression display identical V beta usage but different cytotoxic activities.
Kurt RA; Park JA; Panelli MC; Schluter SF; Marchalonis JJ; Carolus B; Akporiaye ET
J Immunol; 1995 Apr; 154(8):3969-74. PubMed ID: 7706735
[TBL] [Abstract][Full Text] [Related]
15. Secretion of interleukin-10 from murine colon carcinoma cells suppresses systemic antitumor immunity and impairs protective immunity induced against the tumors.
Kawamura K; Bahar R; Natsume W; Sakiyama S; Tagawa M
Cancer Gene Ther; 2002 Jan; 9(1):109-15. PubMed ID: 11916240
[TBL] [Abstract][Full Text] [Related]
16. Regulatory role of T lymphocytes and NK cells in tumor allograft development.
Sobotková E; Nouza K
Neoplasma; 1993; 40(2):75-80. PubMed ID: 8350958
[TBL] [Abstract][Full Text] [Related]
17. Intracamerally induced concomitant immunity: mice harboring progressively growing intraocular tumors are immune to spontaneous metastases and secondary tumor challenge.
Niederkorn JY; Streilein JW
J Immunol; 1983 Nov; 131(5):2587-94. PubMed ID: 6415174
[TBL] [Abstract][Full Text] [Related]
18. Hybrid resistance to BALB/c plasmacytomas: F1 hybrid anti-MPC-11 immunological responses correlated with resistance to tumor challenge.
Marsili MA; Walker MC; Phillips-Quagliata JM
Cancer Res; 1986 Jan; 46(1):190-7. PubMed ID: 3484380
[TBL] [Abstract][Full Text] [Related]
19. Destructive and nondestructive patterns of immune rejection of syngeneic intraocular tumors.
Knisely TL; Luckenbach MW; Fischer BJ; Niederkorn JY
J Immunol; 1987 Jun; 138(12):4515-23. PubMed ID: 3108394
[TBL] [Abstract][Full Text] [Related]
20. Vaccination with viable human umbilical vein endothelial cells prevents metastatic tumors by attack on tumor vasculature with both cellular and humoral immunity.
Chen XY; Zhang W; Zhang W; Wu S; Bi F; Su YJ; Tan XY; Liu JN; Zhang J
Clin Cancer Res; 2006 Oct; 12(19):5834-40. PubMed ID: 17020991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
